University Hospital, Tours   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Tours France (1658)

Organization Overview

First Clinical Trial
2019
NCT03800524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centre d’Investigation Clinique 1415 | Centre Oncologie Radiothérapie 37 - CORT37 | CHRU DE TOURS | Dr Christophe LENCLUD | Hôpital Bretonneau - University Hospital of Tours | INSERM CIC-P 1415, University Hospital Center of Tours | Tours University Hospital | University Hospital of TOURS | University Hospital of TOURS;INSERM 1246 SPHERE | University Hospital, Tours